CH391679A - Verfahren zur Herstellung neuer Zuckerderivate - Google Patents
Verfahren zur Herstellung neuer ZuckerderivateInfo
- Publication number
- CH391679A CH391679A CH6817059A CH6817059A CH391679A CH 391679 A CH391679 A CH 391679A CH 6817059 A CH6817059 A CH 6817059A CH 6817059 A CH6817059 A CH 6817059A CH 391679 A CH391679 A CH 391679A
- Authority
- CH
- Switzerland
- Prior art keywords
- radicals
- hydroxyl groups
- glucofuranoside
- acids
- compounds
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 11
- 150000001875 compounds Chemical class 0.000 claims description 13
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- -1 heterocyclic carboxylic acids Chemical class 0.000 claims description 6
- 239000004215 Carbon black (E152) Substances 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- 150000001298 alcohols Chemical class 0.000 claims description 5
- 229930195733 hydrocarbon Natural products 0.000 claims description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- 150000007513 acids Chemical class 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 125000003118 aryl group Chemical group 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 150000002989 phenols Chemical class 0.000 claims description 3
- 238000006266 etherification reaction Methods 0.000 claims description 2
- 230000001419 dependent effect Effects 0.000 claims 2
- 125000000654 isopropylidene group Chemical group C(C)(C)=* 0.000 claims 2
- 229940100198 alkylating agent Drugs 0.000 claims 1
- 239000002168 alkylating agent Substances 0.000 claims 1
- 230000032050 esterification Effects 0.000 claims 1
- 238000005886 esterification reaction Methods 0.000 claims 1
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 40
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 28
- 239000000243 solution Substances 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 238000009835 boiling Methods 0.000 description 12
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 11
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 10
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 9
- 239000003921 oil Substances 0.000 description 9
- 235000019198 oils Nutrition 0.000 description 9
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 8
- 238000003756 stirring Methods 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 229960000583 acetic acid Drugs 0.000 description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 239000012362 glacial acetic acid Substances 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 3
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- XPFVYQJUAUNWIW-UHFFFAOYSA-N furfuryl alcohol Chemical compound OCC1=CC=CO1 XPFVYQJUAUNWIW-UHFFFAOYSA-N 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 238000005292 vacuum distillation Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- BGGCXQKYCBBHAH-OZRXBMAMSA-N (1r)-1-[(3ar,5r,6s,6ar)-6-hydroxy-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-5-yl]ethane-1,2-diol Chemical compound O1[C@H]([C@H](O)CO)[C@H](O)[C@H]2OC(C)(C)O[C@H]21 BGGCXQKYCBBHAH-OZRXBMAMSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- MIPWIPFSFNFSBO-MCIOHCJDSA-N CCOC([C@@H]1O)O[C@H]([C@@](C)(C(C)O)O)[C@]1(C)O Chemical compound CCOC([C@@H]1O)O[C@H]([C@@](C)(C(C)O)O)[C@]1(C)O MIPWIPFSFNFSBO-MCIOHCJDSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 239000002841 Lewis acid Substances 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000002026 chloroform extract Substances 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 150000007517 lewis acids Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229940124530 sulfonamide Drugs 0.000 description 2
- 150000003456 sulfonamides Chemical class 0.000 description 2
- 150000003460 sulfonic acids Chemical class 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical group C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- LQLJZSJKRYTKTP-UHFFFAOYSA-N 2-dimethylaminoethyl chloride hydrochloride Chemical compound Cl.CN(C)CCCl LQLJZSJKRYTKTP-UHFFFAOYSA-N 0.000 description 1
- MVQVNTPHUGQQHK-UHFFFAOYSA-N 3-pyridinemethanol Chemical compound OCC1=CC=CN=C1 MVQVNTPHUGQQHK-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 206010002199 Anaphylactic shock Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- LSHXJSOJQYVSPT-FPPQFYMJSA-N CCOC([C@]1(C(C)=O)O)O[C@H]([C@@](C)(C(C)O)O)[C@]1(C)O Chemical group CCOC([C@]1(C(C)=O)O)O[C@H]([C@@](C)(C(C)O)O)[C@]1(C)O LSHXJSOJQYVSPT-FPPQFYMJSA-N 0.000 description 1
- OKJLHVWAPXWZOL-FVQVIHIZSA-N CCOC([C@]1(C(C)=O)O)O[C@H]([C@@](CC2=CC=CC=C2)(C(CC2=CC=CC=C2)O)O)[C@]1(CC1=CC=CC=C1)O Chemical compound CCOC([C@]1(C(C)=O)O)O[C@H]([C@@](CC2=CC=CC=C2)(C(CC2=CC=CC=C2)O)O)[C@]1(CC1=CC=CC=C1)O OKJLHVWAPXWZOL-FVQVIHIZSA-N 0.000 description 1
- CZXFKJWASIFHJK-FPPQFYMJSA-N CCOC([C@]1(CC(O)=O)O)O[C@H]([C@@](C)(C(C)O)O)[C@]1(C)O Chemical compound CCOC([C@]1(CC(O)=O)O)O[C@H]([C@@](C)(C(C)O)O)[C@]1(C)O CZXFKJWASIFHJK-FPPQFYMJSA-N 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000001986 anti-endotoxic effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 150000008107 benzenesulfonic acids Chemical class 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000004508 fractional distillation Methods 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 238000007327 hydrogenolysis reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229960004738 nicotinyl alcohol Drugs 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical class OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- FDRCDNZGSXJAFP-UHFFFAOYSA-M sodium chloroacetate Chemical compound [Na+].[O-]C(=O)CCl FDRCDNZGSXJAFP-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- ZPHGMBGIFODUMF-UHFFFAOYSA-N thiophen-2-ylmethanol Chemical group OCC1=CC=CS1 ZPHGMBGIFODUMF-UHFFFAOYSA-N 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/18—Acyclic radicals, substituted by carbocyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Saccharide Compounds (AREA)
Priority Applications (19)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH6817059A CH391679A (de) | 1959-01-10 | 1959-01-10 | Verfahren zur Herstellung neuer Zuckerderivate |
| DK462859AA DK126687B (da) | 1959-01-10 | 1959-12-21 | Analogifremgangsmåde til fremstilling af glucofuranosider eller 2-0-acylderivater deraf. |
| US862799A US3157634A (en) | 1959-01-10 | 1959-12-30 | Glucofuranosides and process for their preparation |
| DE19591792718 DE1792718A1 (de) | 1959-01-10 | 1959-12-30 | Pharmazeutische Praeparate enthaltende Glucofuranoside |
| DE19591443591 DE1443591A1 (de) | 1959-01-10 | 1959-12-30 | Glucofuranoside und Verfahren zu ihrer Herstellung |
| DE19591792716 DE1792716A1 (de) | 1959-01-10 | 1959-12-30 | Pharmazeutische Praeparate,enthaltend Glucofuranoside |
| DE19591418126 DE1418126A1 (de) | 1959-01-10 | 1959-12-30 | Glucofuranoside und Verfahren zu deren Herstellung |
| GB1962/61A GB909279A (en) | 1959-01-10 | 1959-12-31 | Pharmaceutical preparations containing d-glucofuranosides |
| GB44483/59A GB909278A (en) | 1959-01-10 | 1959-12-31 | New sugar derivatives, a process for their manufacture and pharmaceutical preparations containing them |
| ES0254705A ES254705A1 (es) | 1959-01-10 | 1959-12-31 | Procedimiento para la obtenciën de nuevos derivados del azucar |
| BE586370A BE586370A (fr) | 1959-01-10 | 1960-01-08 | Procédé de préparation de 1-amino (secondaire)-1-désoxy-cétoses |
| BE586369A BE586369A (fr) | 1959-01-10 | 1960-01-08 | Procédé de préparation de nouveaux glucofuranosides 3,5,6-substitués |
| BE586371A BE586371A (fr) | 1959-01-10 | 1960-01-08 | Dérivés asymétriques d'alkylènediamines leur préparation et leur utilisation |
| AT12660A AT241483B (de) | 1959-01-10 | 1960-01-08 | Verfahren zur Herstellung neuer Zuckerderivate |
| SE178/60A SE301637B (fr) | 1959-01-10 | 1960-01-09 | |
| FR836981A FR348M (fr) | 1959-01-10 | 1960-08-29 | Nouveau glucofuranoside 3,5,6-substitué utilisable en thérapeutique. |
| DK434960AA DK127056B (da) | 1959-01-10 | 1960-11-03 | Analogifremgangsmåde til fremstilling af glucofuranosider. |
| SE04079/65A SE332974B (fr) | 1959-01-10 | 1965-03-30 | |
| MY196616A MY6600016A (en) | 1959-01-10 | 1966-12-31 | New sugar derivatives, a process for their manufacture and pharmaceutical preparations containing them |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH6817059A CH391679A (de) | 1959-01-10 | 1959-01-10 | Verfahren zur Herstellung neuer Zuckerderivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH391679A true CH391679A (de) | 1965-05-15 |
Family
ID=4528520
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH6817059A CH391679A (de) | 1959-01-10 | 1959-01-10 | Verfahren zur Herstellung neuer Zuckerderivate |
Country Status (2)
| Country | Link |
|---|---|
| BE (2) | BE586371A (fr) |
| CH (1) | CH391679A (fr) |
-
1959
- 1959-01-10 CH CH6817059A patent/CH391679A/de unknown
-
1960
- 1960-01-08 BE BE586371A patent/BE586371A/fr unknown
- 1960-01-08 BE BE586370A patent/BE586370A/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BE586371A (fr) | 1960-07-08 |
| BE586370A (fr) | 1960-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1418126A1 (de) | Glucofuranoside und Verfahren zu deren Herstellung | |
| CH416600A (de) | Verfahren zur Herstellung von Farnesylessigsäureestern | |
| DE1244777B (de) | Verfahren zur Herstellung von 7alpha-Methyl-16alpha-hydroxy-oestron bzw. -3, 16-diacetat | |
| CH499507A (de) | Verfahren zur Herstellung von Aldehyden der Pregnanreihe und ihrer Derivate | |
| CH505815A (de) | Verfahren zur Herstellung von Furanverbindungen | |
| CH391679A (de) | Verfahren zur Herstellung neuer Zuckerderivate | |
| DE953077C (de) | Verfahren zur Herstellung von 5-Pregnen-17ª, 21-diol-3, 11, 20-trion-3, 20-dialkylen-ketalen | |
| CH544752A (de) | Verfahren zur Herstellung neuer Glucoside | |
| DE1793462B2 (de) | N-Aryl-anthranilsäureester monosubstituierter gem-Diole, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate | |
| DE1418126C (de) | Glucofuranoside, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate | |
| DE2319873C2 (de) | 16-O-Alkylderivate von Gitoxigenin-digitoxosiden, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel | |
| DE1443591C (de) | Glucofuranoside, Verfahren zu ihrer Herstellung und diese enthaltende pharma zeutische Präparate | |
| CH407077A (de) | Verfahren zur Herstellung neuer Zuckerderivate | |
| AT217645B (de) | Verfahren zur Herstellung von neuen Derivaten des Aldosterons | |
| DE1961867A1 (de) | Verfahren zur Herstellung von Aldehyden der Pregnanreihe und ihrer Derivate | |
| CH540892A (de) | Verfahren zur Herstellung von Aldehyden der Pregnanreihe und ihrer Derivate | |
| AT224116B (de) | Verfahren zur Herstellung von neuen, 4-substituierten 1,2-Diaryl-3,5-dioxo-pyrazolidinen | |
| CH553770A (de) | Verfahren zur herstellung von aldehyden der pregnanreihe und ihrer derivate. | |
| CH499509A (de) | Verfahren zur Herstellung von Aldehyden der Pregnanreihe und ihrer Derivate | |
| DE2821189A1 (de) | Coriolinderivate, deren herstellung und diese enthaltende pharmazeutische praeparate | |
| CH598283A5 (en) | 2-chloro-pregnane-21-aldehyde derivs | |
| DE1443591B (de) | Glucofuranoside, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate | |
| CH598156A5 (en) | 2-chloro-pregnane-21-aldehyde derivs | |
| DE1620446A1 (de) | Verfahren zur Herstellung von 4,4'-Dihydroxydiphenylmethan-Derivaten | |
| DE1064067B (de) | Verfahren zur Herstellung der therapeutisch wirksamen, in 4-Stellung durch einen gamma-oder delta-Oxybutylrest substituierten 1, 2-Diphenyl-3, 5-dioxo-pyrazolidine |